Big, big news out of San Francisco that could have major playoff implications: Melky Cabrera has been suspended 50 games for a positive testosterone test.
That knocks him out for the rest of the season — the Giants only have 45 games left — and presumably the postseason. Though I’ll check to see whether suspensions can be counted off with postseason games. If they can. He’d be available for a theoretical NLCS.
Oh, and it appears that Melky lied to Andrew Baggarly of CSNBayArea.com about it too, so that’s fun.
Cabrera is hitting .346/.390/.516 on the year and, until Buster Posey’s hot streak of late, was the Giants’ offensive MVP for most of the season. Now … he’s gone. And it hurts not just the Giants: Cabrera will be a free agent after the season is over, and now his free agent money drive is all gone.
UPDATE: Cabrera just made a statement and he made no excuses:
“My positive test was the result of my use of a substance I should not have used. I accept my suspension under the Joint Drug Program and will try to move on with my life. I am deeply sorry for my mistake and I apologize to my teammates, to the San Francisco Giants organization and to the fans for letting them down.”
Wow. Can’t remember many violators who actually owned up without caveat.
Mariners’ right-hander Arquimedes Caminero is nearing a deal with the Yomiuri Giants of Nippon Professional Baseball, according to Bob Dutton of the Tacoma News Tribune. The club has reportedly agreed to sell the 29-year-old’s contract, Dutton writes, though no official move has been announced by either team yet. Caminero is under club control through 2020 and currently ineligible for arbitration.
The right-hander began the 2016 season with the Pirates but was sent to the Mariners in a trade for Seattle minor leaguers Jake Brentz and Pedro Vasquez in order to clear space in the Bucs’ bullpen. With the Mariners, Caminero produced a 3.66 ERA and 8.2 K/9 through 19 2/3 innings in the second half of the year. Although he boasts an electric fastball, one which consistently averaged 98.7 m.p.h. in 2016, his success rate has been tempered by poor control throughout his major league career. According to Dutton, the Mariners’ willingness to sell Caminero’s contract was a strong indication that they did not see him as a viable contender for their 2017 bullpen or as a potential trade chip further down the line.
Should the deal go through, the right-hander will be the second former Mariner to sign with a Japanese club for the 2017 season. Per Dutton’s report, outfielder Stefen Romero also picked up a contract with the Orix Buffaloes of NPB in late November.
During the Pirates’ FanFest on Saturday, right-hander Gerrit Cole announced that he is back up to full health after being shut down with elbow inflammation in September. Per Rob Biertempfel of the Pittsburgh Tribune-Review, Cole said he’ll start a throwing program on Monday as he works on regaining his form for the 2017 season.
The 26-year-old pitched through 116 innings for the Pirates in 2016, delivering a 3.88 ERA and 2.5 WARP before landing on the disabled list in June with a triceps strain and again in August with elbow inflammation. It was a steep drop for the right-hander, who saw a considerable spike in his ERA and BB/9 rate and struggled to strike out batters at the 8.7 mark he managed in 2015.
The upside? Inflammation was the worst of Cole’s issues in 2016, and while the newfound health issues didn’t help his case for an extension, a more serious injury doesn’t appear to be on the horizon.